As of January 22, 2025, Terns Pharmaceuticals (TERN) has a market cap of $0.40 billion USD. According to our data, Terns Pharmaceuticals is ranked No.6399 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.40 B |
-15.70%
|
Dec 31, 2024 | $0.47 B |
-14.64%
|
Dec 29, 2023 | $0.55 B |
-36.25%
|
Dec 30, 2022 | $0.86 B |
43.99%
|
Dec 31, 2021 | $0.60 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Madrigal Pharmaceuticals
MDGL
|
$7.08 B |
-0.000 M
|
USA
|
Viking Therapeutics
VKTX
|
$3.79 B |
-0.000 M
|
USA
|
Galmed Pharmaceuticals
GLMD
|
$4.72 M |
0.000 M
|
Israel
|
Akero Therapeutics
AKRO
|
$1.75 B |
0.000 M
|
USA
|
89bio
ETNB
|
$0.79 B |
0.000 M
|
USA
|
Genfit
GNFT
|
$0.18 B |
-0.000 M
|
France
|
Enanta Pharmaceuticals
ENTA
|
$0.11 B |
0.000 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.77 B |
0.000 M
|
USA
|
Pfizer
PFE
|
$147.43 B |
0.004 M
|
USA
|
Market Cap | = | TERN Stock Price | * | TERN Shares Outstanding |
= | $4.67 | * | 84.94 M | |
= | $0.40 B |